The State-by-State Cannabis Policy Gap Has a Dollar Figure

April 27, 2026

By: Wiss Team

Wiss Team

The National Organization for the Reform of Marijuana Laws chose the week of 4/20 to launch its 2026 Cannabis Freedom Survey, asking consumers across the country to describe the policy environment where they live. For cannabis business owners, the survey’s most consequential question is not about consumer sentiment. It is the one embedded in its premise: the gap between what the laws say and how people actually experience them varies enormously by location. That geographic variation is not just a policy story. It is a financial operations story.

What the NORML Survey Is Measuring

The 2026 Cannabis Freedom Survey, published ahead of the April 20 cannabis holiday, asks respondents in U.S. states and internationally to assess their local policy environment across several dimensions. Questions address the legal accessibility of cannabis for adults, the level of concern consumers carry about legal consequences, and the most meaningful changes that would improve their experience as consumers.

NORML Development Director JM Pedini described the survey’s purpose as capturing the gap between what laws formally permit and how people actually experience those laws on a daily basis. “In some jurisdictions, cannabis comes with real freedom,” Pedini said. “In others, it still comes with real consequences.”

The survey results are expected to be published in the days leading up to 4/20.

Why Geographic Variation Is the Central Financial Challenge for Cannabis Operators

The legal patchwork the survey is documenting has direct consequences for how cannabis businesses structure their operations, file their taxes, and plan for growth.

Adult-use cannabis is currently legal in 24 states. Medical marijuana operates in 42 states. That is 42 different regulatory frameworks with 42 different compliance requirements, licensing structures, inventory tracking mandates, and tax treatments layered on top of the federal complexity that every cannabis operator already carries, regardless of which state they are in.

The federal layer is the one that has defined cannabis business finance since the industry emerged. Section 280E of the Internal Revenue Code prohibits state-legal marijuana businesses from deducting ordinary business expenses at the federal level because marijuana remains a Schedule I controlled substance. The result is a tax structure unlike any other in the legal industry: cannabis operators effectively pay federal income tax on gross revenue rather than net income, with some reporting effective federal tax rates as high as 80%.

The only deduction that survives 280E is the cost of goods sold. Everything else, rent, payroll for non-production staff, marketing, and administrative expenses, is non-deductible at the federal level.

The Rescheduling Window and What It Changes

On December 18, 2025, President Trump signed Executive Order 14370 directing the DEA to complete the rulemaking process to move marijuana from Schedule I to Schedule III in the most expeditious manner permitted by law. As of April 2026, rescheduling has not yet taken effect. The administrative process, including an unresolved interlocutory appeal, remains pending.

If rescheduling to Schedule III is finalized, Section 280E would cease to apply to marijuana businesses. Cannabis operators would gain access to standard business expense deductions for the first time. Industry estimates place the aggregate annual tax savings across the sector at approximately $2.3 billion, with cannabis retailers in higher-volume states potentially saving an average of $805,000 per store annually, according to Cannabis Business Times analysis.

Rescheduling would not, however, federally legalize recreational cannabis. Marijuana in Schedule III remains a controlled substance. The state-by-state patchwork documented in the NORML survey would continue to define where and how businesses can legally operate and sell.

What the Policy Gap Means for Multi-State and Growth-Stage Operators

For cannabis businesses evaluating expansion, the geographic variation in consumer experience that the NORML survey measures translates directly into operational implications. States with established, functioning adult-use markets, strong regulatory frameworks, and consumer confidence produce different financial profiles than states where the policy environment remains restrictive or uncertain.

Multi-state operators carry this complexity in their accounting architecture. Different states require different chart-of-accounts structures, different inventory tracking methodologies under seed-to-sale compliance requirements, and different approaches to cost allocation between production and retail activities, which is the central technical question under Section 280E.

The businesses best positioned to benefit from rescheduling, when it arrives, are those that have used the current period to review their entity structures, audit their COGS methodologies, and ensure their financial operations are built for a post-280E world rather than optimized only for the constraints of the current one.

Wiss Cannabis Tax Advisory

Wiss works with cannabis businesses on the specific tax and accounting challenges of operating in a federally complex, state-regulated industry. That includes Section 280E compliance and COGS methodology, multi-state regulatory and financial reporting, entity structure review ahead of rescheduling, and the financial infrastructure that institutional investors and banking partners require. If your cannabis business has not had its tax structure reviewed in the context of current rescheduling momentum, contact the Wiss team.

AI Disclosure: This article was produced with AI writing assistance and reviewed by the Wiss editorial team. Original reporting by Tom Angell, Marijuana Moment, published April 13, 2026.